Utility of the GeneSearch Breast Lymph Node Assay for the Rapid Evaluation of Sentinel Lymph Nodes in Breast Cancer

作者：Funasako Yawara^*; Uenosono Yoshikazu; Hirata Munetsugu; Arigami Takaaki; Yanagita Shigehiro; Arima Hideo; Ehi Katsuhiko; Kijima Yuko; Yoshinaka Heiji; Natsugoe Shoji

来源：Cancer, 2010, 116(19): 4450-4455.

DOI：10.1002/cncr.25479

• breast cancer
• sentinel lymph node
• breast lymph node assay
• reverse transcriptase-polymerase chain reaction
• micrometastasis

BACKGROUND: The potential for reducing the need for second surgery for axillary lymph node dissection (ALND) has made the intraoperative evaluation of sentinel lymph nodes (SLNs) attractive. The goal of the current study was to evaluate the clinical application of the breast lymph node (BLN) assay, a real-time reverse transcriptase-polymerase chain reaction assay for SLN metastases, by comparing this test with routine pathologic examination. METHODS: A total of 117 patients with breast cancer underwent breast surgery with SLN biopsy. Each SLN was cut in half along the plane of the longest dimension. Half of each lymph node was examined by the 2 markers of the BLN assay, mammaglobin and cytokeratin 19, and the other half was examined by hematoxylin and eosin staining (H&E) and immunohistochemical staining (IHC) for pancytokeratins. RESULTS: A total of 204 SLNs were obtained from 117 patients. H&E staining identified metastases in 31 SLNs (15.2%), and IHC staining detected metastases in 6 SLNs; 40 SLNs from 32 patients were found to be positive for metastasis using the BLN assay. The assay results were correlated with the pathologic diagnoses by H&E and IHC staining (P <.001). The sensitivity of the BLN assay compared with pathologic findings classified according to the TNM classification was 95.7% for macrometastases, 60.0% for micrometastases, and 55.6% for isolated tumor cells. CONCLUSIONS: The 2-marker BLN assay performs in a manner that is comparable to, and analyzes more tissue than, routine pathologic examination. Therefore, clinical intraoperative use of the BLN assay for SLNs may result in a reduction in the need for second surgery for ALND. Cancer 2010;116:4450-5.

• 出版日期2010-10-1